[Model of coxsackievirus B3 persistent infection in orally-inoculated BALB/c mouse]. 2004

R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
Laboratoire de bactériologie-virologie (GIMAP), faculté de médecine de Saint-Etienne, 42055 Saint-Etienne, France.

Many mouse models of human enterovirus disease have been pro- posed, concerning both acute and persistent infection. However, rather paradoxically since the usual way of contamination is fecal-oral, most of them used a systemic route of infection. The aim of the present work was to follow the development of an experimental enterovirus infection and to study the viral persistence at the organ level. Twenty-eight female 3-week old BALB/c mice were infected with 5 x 10(4) TCID(50) of coxsackievirus B3 (CV-B3), Nancy strain, by oral route using a rigid cannula introduced into the stomach. The kinetics of infection was studied by sacrificing 2 animals at different times post infection (from 1 hour to 90 days). The presence of the virus in various organs (small intestine, heart, pancreas, lung, spleen, kidney, liver) was studied by cell culture and RT-PCR. As soon as one hour post infection, the virus was detected in the small intestine. In the heart, the virus was present at 24 and 48 hours post infection by RT-PCR and culture, respectively. At 5 days post infection, all the organs but the liver were found infected. The virus was detected up to 15 days in kidney, 21 days in pancreas, 30 days in lung and spleen, and 45 days in intestine, by both culture and PCR. The heart was still found infected 90 days post infection by both techniques. These results show the dramatic cardiotropism of CV-B3 inoculated by oral route, with a detection of the virus very soon in the course of infection (24 hours) and a persistence of the virus for more than 3 months. The intestine, the initial target of enterovirus infection, can also be considered as a site of viral persistence.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009055 Mouth The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper. Oral Cavity,Cavitas Oris,Cavitas oris propria,Mouth Cavity Proper,Oral Cavity Proper,Vestibule Oris,Vestibule of the Mouth,Cavity, Oral
D003384 Coxsackievirus Infections A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS. Coxsackie Virus Infections,Infections, Coxsackie Virus,Infections, Coxsackievirus,Coxsackie Virus Infection,Coxsackievirus Infection
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
November 2013, Journal of virology,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
January 2015, Experimental animals,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
January 1988, The Journal of general virology,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
May 2017, Antiviral research,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
January 1984, Archives of virology,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
September 1981, The Journal of infectious diseases,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
July 2009, The Canadian journal of cardiology,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
May 2005, Medical microbiology and immunology,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
June 2021, Viruses,
R Harrath, and F Douche-Aourik, and T Bourlet, and A Ismail, and S Omar, and M Aouni, and B Pozzetto
May 2004, Medical microbiology and immunology,
Copied contents to your clipboard!